UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - glioblastoma
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Integrated Molecular and Lipidomic Analysis of Glioma Tumors Identifies Therapeutic Vulnerabilites (UCLA Case No. 2023-210)
UCLA researchers in the Department of Molecular and Medical Pharmacology have uncovered a novel therapeutic target for
Glioblastoma
leveraging an extensive lipidomic and transcriptomic database. BACKGROUND: Glioblastoma (GBM) is a fast-growing and aggressive brain tumor. The National Brain Tumor Society predicted that over 14,000 people in the United...
Published: 3/11/2024
|
Inventor(s):
David Nathanson
Keywords(s):
Brain cancer
,
Brain Tumor
,
cancer target
,
cell death
,
ferroptosis
,
Glioblastoma
,
lipidomics
Category(s):
Therapeutics > Oncology
Targeting the Intrinsic Apoptotic Machinery in
Glioblastoma
Multiforme (GBM) (UCLA Case No. 2020-446)
UCLA researchers in the Department of Molecular and Medical Pharmacology identified the mechanisms of apoptotic resistance in
glioblastoma
multiforme (GBM) and developed a novel therapy to treat GBM. BACKGROUND: Glioblastoma (GBM) is the most aggressive form of brain tumor. Therapeutic options for GBM are limited and suboptimal. Treatment usually...
Published: 2/16/2024
|
Inventor(s):
David Nathanson
Keywords(s):
anti-apoptotic inhibitor
,
Anti-apoptotic pathway
,
Apoptosis
,
Brain Tumor
,
Glioblastoma
,
irradiation
,
p53
,
temozolomide
Category(s):
Therapeutics > Oncology